Novavax is a biotech company with a proven technology, focused on developing our R&D assets and establishing partnerships to help protect health.

May 20, 2025 · The Novavax vaccine is one of three vaccines available in the U.S. for the prevention of COVID-19 and the only one that does not use the relatively new mRNA vaccine …

The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, [1] among others, is a subunit COVID-19 vaccine developed by Novavax and the Coalition for …

May 19, 2025 – The FDA has approved the Novavax COVID-19 vaccine, a protein-based alternative to mRNA shots, with some limits on who can get it.

6 hours ago · We came across a bullish thesis on Novavax, Inc. on Ridire Research’s Substack. In this article, we will summarize the bulls’ thesis on NVAX. Novavax, Inc.’s share was trading …

On August 27, 2025, the Food and Drug Administration revoked the Emergency Use Authorization (EUA) for Novavax COVID-19 Vaccine, Adjuvanted. Nuvaxovid (COVID-19 Vaccine, …

Sep 10, 2024 · Novavax COVID-19 Vaccine, Adjuvanted is indicated for individuals 12 years of age and older. Novavax's product will be presented in prefilled syringes, and there is one …

Aug 27, 2025 · Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including …

Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company's first and only commercial product is the Novavax COVID-19 vaccine.

Sep 10, 2024 · Novavax is a protein subunit vaccine and is based on a more traditional vaccination approach than mRNA vaccines. It contains a lab-made version of the SARS-CoV …